SLC5A2 and chronic kidney disease: A study that measured 24 h urine volumes in patients with chronic kidney disease on a standardized sodium diet treated with SGLT2 inhibitors observed no increase in diuresis and concluded that the activation of compensatory mechanisms within the kidney prevents increased diuresis [17].